Invention Grant
- Patent Title: Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
-
Application No.: US15345860Application Date: 2016-11-08
-
Publication No.: US09932404B2Publication Date: 2018-04-03
- Inventor: Mark Cunningham , Yiqing Feng , Katharine Heeringa , Jinquan Luo , Robert Rauchenberger , Mark Rutz , Lani San Mateo , Robert Sarisky , Raymond Sweet , Fang Teng , Alexey Teplyakov , Sheng-Jiun Wu
- Applicant: Janssen Biotech, Inc.
- Applicant Address: US PA Horsham
- Assignee: Janssen Biotech, Inc.
- Current Assignee: Janssen Biotech, Inc.
- Current Assignee Address: US PA Horsham
- Agency: Bozicevic Field & Francis, LLP
- Agent Paula A. Borden
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/28 ; C07H21/04 ; C12N15/117 ; C07K14/705 ; C12N5/10 ; C12N5/12 ; C12N15/63 ; A61K39/00
Abstract:
Toll Like Receptor 3 (TLR3) antibody antagonists, polynucleotides encoding TLR3 antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.
Public/Granted literature
- US20170058041A1 Toll-Like Receptor 3 Antagonists Public/Granted day:2017-03-02
Information query
